Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000221722 | SCV000272347 | uncertain significance | not specified | 2015-06-22 | criteria provided, single submitter | clinical testing | The p.Met338Thr variant in RBM20 has not been previously reported in individuals with cardiomyopathy and was absent from large population studies. Computational prediction tools and conservation analysis suggest that the p.Met338Thr variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, the clinical significance of the p.Met338Th r variant is uncertain. |
Center for Advanced Laboratory Medicine, |
RCV000852629 | SCV000995333 | likely benign | Primary dilated cardiomyopathy | 2019-05-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001206594 | SCV001377909 | likely benign | Dilated cardiomyopathy 1DD | 2024-01-04 | criteria provided, single submitter | clinical testing | |
University of Washington Center for Mendelian Genomics, |
RCV000852629 | SCV001434753 | uncertain significance | Primary dilated cardiomyopathy | no assertion criteria provided | research |